156 related articles for article (PubMed ID: 32094232)
1. Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells.
Tabata Y; Shidoji Y
J Lipid Res; 2020 May; 61(5):778-789. PubMed ID: 32094232
[TBL] [Abstract][Full Text] [Related]
2. Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in
Tabata Y; Shidoji Y
Metabolites; 2022 Feb; 12(2):. PubMed ID: 35208214
[TBL] [Abstract][Full Text] [Related]
3. Geranylgeraniol oxidase activity involved in oxidative formation of geranylgeranoic acid in human hepatoma cells.
Mitake M; Shidoji Y
Biomed Res; 2012 Feb; 33(1):15-24. PubMed ID: 22361882
[TBL] [Abstract][Full Text] [Related]
4. Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.
Shidoji Y; Tabata Y
J Lipid Res; 2019 Mar; 60(3):579-593. PubMed ID: 30622150
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Decrease in Hepatic Geranylgeranoic Acid Content in C3H/HeN Mice and Its Oral Supplementation Prevents Spontaneous Hepatoma.
Tabata Y; Omori M; Shidoji Y
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564450
[TBL] [Abstract][Full Text] [Related]
6. Geranylgeranoic acid, a bioactive and endogenous fatty acid in mammals: a review.
Shidoji Y
J Lipid Res; 2023 Jul; 64(7):100396. PubMed ID: 37247782
[TBL] [Abstract][Full Text] [Related]
7. TLR4-mediated pyroptosis in human hepatoma-derived HuH-7 cells induced by a branched-chain polyunsaturated fatty acid, geranylgeranoic acid.
Yabuta S; Shidoji Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270855
[TBL] [Abstract][Full Text] [Related]
8. Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs.
Shidoji Y; Ogawa H
J Lipid Res; 2004 Jun; 45(6):1092-103. PubMed ID: 15060084
[TBL] [Abstract][Full Text] [Related]
9. A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis.
Shidoji Y; Iwao C
Biochem Biophys Rep; 2021 Dec; 28():101176. PubMed ID: 34869922
[TBL] [Abstract][Full Text] [Related]
10. Rapid downregulation of cyclin D1 induced by geranylgeranoic acid in human hepatoma cells.
Shimonishi S; Muraguchi T; Mitake M; Sakane C; Okamoto K; Shidoji Y
Nutr Cancer; 2012 Apr; 64(3):473-80. PubMed ID: 22369110
[TBL] [Abstract][Full Text] [Related]
11. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.
Takeda Y; Nakao K; Nakata K; Kawakami A; Ida H; Ichikawa T; Shigeno M; Kajiya Y; Hamasaki K; Kato Y; Eguchi K
Jpn J Cancer Res; 2001 Sep; 92(9):918-25. PubMed ID: 11572758
[TBL] [Abstract][Full Text] [Related]
12. Induction of an incomplete autophagic response by cancer-preventive geranylgeranoic acid (GGA) in a human hepatoma-derived cell line.
Okamoto K; Sakimoto Y; Imai K; Senoo H; Shidoji Y
Biochem J; 2011 Nov; 440(1):63-71. PubMed ID: 21787360
[TBL] [Abstract][Full Text] [Related]
13. Induction of nuclear translocation of mutant cytoplasmic p53 by geranylgeranoic acid in a human hepatoma cell line.
Iwao C; Shidoji Y
Sci Rep; 2014 Mar; 4():4419. PubMed ID: 24658405
[TBL] [Abstract][Full Text] [Related]
14. Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus.
Obata Y; Kubota-Sakashita M; Kasahara T; Mizuno M; Nemoto T; Kato T
Sci Rep; 2022 Jan; 12(1):17. PubMed ID: 34996979
[TBL] [Abstract][Full Text] [Related]
15. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
van Beek E; Löwik C; Karperien M; Papapoulos S
Bone; 2006 Feb; 38(2):167-71. PubMed ID: 16165408
[TBL] [Abstract][Full Text] [Related]
16. Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes.
Ganic E; Johansson JK; Bennet H; Fex M; Artner I
Biochem Biophys Res Commun; 2015 Dec; 468(4):629-35. PubMed ID: 26546820
[TBL] [Abstract][Full Text] [Related]
17. Increase in plasma concentrations of geranylgeranoic Acid after turmeric tablet intake by healthy volunteers.
Mitake M; Ogawa H; Uebaba K; Shidoji Y
J Clin Biochem Nutr; 2010 May; 46(3):252-8. PubMed ID: 20490321
[TBL] [Abstract][Full Text] [Related]
18. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase B (MAOB)-containing structures in MAOA-deficient transgenic mice.
Ikemoto K; Kitahama K; Seif I; Maeda T; De Maeyer E; Valatx JL
Brain Res; 1997 Oct; 771(1):121-32. PubMed ID: 9383015
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatment.
Iwao C; Shidoji Y
Biomed Res; 2015; 36(6):371-81. PubMed ID: 26700591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
